|
|
| 0.126 Delayed Data As of Feb 27 |  -0.008 / -5.97%Today’s Change | 0.11 Today|||52-Week Range 1.08 | -30.77% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Rock Creek Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +1,487.30% increase from the last price of 0.13.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.
